- Home
- OGN vs SPR Comparison
OGN vs SPR Comparison
Compare OGN & SPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- SPR
- Stock Information
- Founded
- OGN 1923
- SPR 1927
- Country
- OGN United States
- SPR United States
- Employees
- OGN N/A
- SPR N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- SPR Military/Government/Technical
- Sector
- OGN Health Care
- SPR Industrials
- Exchange
- OGN Nasdaq
- SPR Nasdaq
- Market Cap
- OGN 4.0B
- SPR 3.9B
- IPO Year
- OGN N/A
- SPR 2006
- Fundamental
- Price
- OGN $13.63
- SPR $30.62
- Analyst Decision
- OGN Hold
- SPR Hold
- Analyst Count
- OGN 5
- SPR 13
- Target Price
- OGN $20.80
- SPR $36.00
- AVG Volume (30 Days)
- OGN 4.0M
- SPR 1.2M
- Earning Date
- OGN 05-01-2025
- SPR 05-06-2025
- Dividend Yield
- OGN 7.75%
- SPR N/A
- EPS Growth
- OGN N/A
- SPR N/A
- EPS
- OGN 3.33
- SPR N/A
- Revenue
- OGN $6,403,000,000.00
- SPR $6,316,600,000.00
- Revenue This Year
- OGN N/A
- SPR $26.57
- Revenue Next Year
- OGN $0.71
- SPR $15.60
- P/E Ratio
- OGN $4.34
- SPR N/A
- Revenue Growth
- OGN 2.23
- SPR 4.44
- 52 Week Low
- OGN $13.87
- SPR $28.92
- 52 Week High
- OGN $23.10
- SPR $37.08
- Technical
- Relative Strength Index (RSI)
- OGN 36.36
- SPR 24.86
- Support Level
- OGN $13.90
- SPR $33.87
- Resistance Level
- OGN $14.94
- SPR $35.92
- Average True Range (ATR)
- OGN 0.54
- SPR 0.69
- MACD
- OGN -0.13
- SPR -0.38
- Stochastic Oscillator
- OGN 3.23
- SPR 3.24
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About SPR Spirit Aerosystems Holdings Inc.
Spirit AeroSystems manufactures aerostructures, particularly fuselages, cockpits, wing sections, engine pylons, and nacelles for commercial and military aircraft. The company was spun out of Boeing in 2005 to become the largest independent supplier of aerostructures for commercial aircraft. Boeing and Airbus are the firm's primary customers—Boeing represented roughly 60% and Airbus roughly 20% of revenue in recent years. The company is highly exposed to Boeing's beleaguered 737 program, which accounts for nearly half the company's revenue. The company plans to be acquired by and reintegrated into Boeing in mid-2025.